PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Boosting the immune system to treat brain cancer

Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth

2013-12-09
(Press-News.org) Contact information: Marta
mcyperli@ucalgary.ca
403-210-3835
University of Calgary
Boosting the immune system to treat brain cancer Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer.

Despite current treatment strategies, the median survival for patients with the most aggressive brain cancer – called glioblastoma, is 15 months. Less than five per cent of patients survive beyond five years.

HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers from the Department of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at human brain tumour samples and discovered that specialized immune cells in brain tumour patients are compromised. The researchers took this discovery and, in an animal model, identified a drug that is able to re-activate those immune cells and reduce brain tumour growth, thereby increasing the lifespan of mice two to three times. Their discovery will be published December 8th in the prestigious journal Nature Neuroscience.

Our brains normally contain specialized cells, called microglia, that defend against injury or infection. "Microglia are the brain's own dedicated immune system," explains Yong. "And in this study, we have formally demonstrated for the first time that these cells are compromised in living brain tumour patients."

As with other forms of cancer, brain tumours start as individual stem-like cells – called brain tumour initiating cells (BTICs). These cells quickly divide and grow, eventually forming a mass, or tumour. Yong and his team have discovered that the tumour disables microglia, permitting the rapid proliferation of BTICs, which ultimately leads to brain tumour growth.

"We refer to this as the battle for the brain, in which early on in the disease, the microglia are trying to destroy the brain tumour initiating cells," says Yong. "But over the course of time, the tumour disables the microglia and we start to see more initiating cells and more rapid tumour growth. We have sought to tip the battle in favour of the brain to suppress the tumour."

In addition to discovering this mechanism, Yong and Sarkar also identified a drug - amphotericin B (AmpB) - to reactivate microglia that in an animal model, showed a significant reduction in brain tumour growth.

"This drug was able to re-activate the disabled microglia," says Sarkar, "thus restoring the body's natural defense mechanisms and restricting the growth of brain tumour initiating cells." The drug they identified is a powerful agent that is already used clinically to treat severe fungal infections of the brain and spinal cord. "It's a rather harsh medication," says Yong. "But we have demonstrated that this drug can be used in very small doses where it is not only well tolerated, but it is also effective in re-programming microglia."

Yong and Sarkar hope this discovery will lead to clinical trials and ultimately to a new standard of care for brain tumour patients.

The finding has already garnered attention from researchers across Canada, including internationally recognized brain tumour scientist and neurosurgeon Dr. James Rutka.

"This research is highly significant as it implies that a commercially available drug, amphotericin B, which has never been used before for patients with gliomas, may be a novel treatment to consider in future trials of patients with this frequently lethal cancer," says Dr. Rutka, Professor and Chair, Department of Surgery, University of Toronto.

### The funding was provided by Alberta Innovates – Health Solutions/Alberta Cancer Foundation. V. Wee Yong is a Canada Research Chair in Neuroimmunology.


ELSE PRESS RELEASES FROM THIS DATE:

Extensive variability in olfactory receptors influences human odor perception

2013-12-09
Extensive variability in olfactory receptors influences human odor perception We each live in a unique odor world PHILADELPHIA (December 8, 2013) – According to Gertrude Stein, "A rose is a rose is a rose," but new research indicates that might not be the case ...

New rearing method may help control of the western bean cutworm

2013-12-09
New rearing method may help control of the western bean cutworm The western bean cutworm is a destructive insect pest of dry beans and corn. Inadequate protocols for laboratory rearing of this insect have hindered controlled efficacy experimentation ...

The invasive Turkestan cockroach is displacing the oriental cockroach in the southwestern US

2013-12-09
The invasive Turkestan cockroach is displacing the oriental cockroach in the southwestern US The Turkestan cockroach, Blatta lateralis (Walker), has become an important invasive species throughout the southwestern United States and has been reported ...

Electrical control of single atom magnets

2013-12-09
Electrical control of single atom magnets The energy needed to change the magnetic orientation of a single atom – which determines its magnetic stability and therefore its usefulness in a variety of future device applications – can be modified by varying the ...

Surprising diversity in aging revealed in nature

2013-12-09
Surprising diversity in aging revealed in nature In our youth we are strong and healthy and then we weaken and die - that's probably how most would describe what ageing is all about. But, in nature, the phenomenon of ageing shows an unexpected diversity of patterns and ...

Concussion secrets unveiled in mice and people

2013-12-09
Concussion secrets unveiled in mice and people NIH scientists film early concussion damage and describe brain's response to injury There is more than meets the eye following even a mild traumatic brain injury. While ...

How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy?

2013-12-09
How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy? 2 pharmacists from UdeM and the Institut universitaire en sante mentale de Montreal give us some answers This news release is available in French. The ...

Peer-review science is taking off on Twitter, but who is tweeting what and why?

2013-12-09
Peer-review science is taking off on Twitter, but who is tweeting what and why? The most tweeted peer-reviewed articles published between 2010 and 2012, and the trends associated with their social media success, have been identified by Stefanie ...

High chair-related injuries to children on the rise

2013-12-09
High chair-related injuries to children on the rise Every hour, every day a child is taken to a hospital as injuries surge 22 percent (COLUMBUS, Ohio) – High chairs and booster seats are commonly used to help make feeding young children ...

Innovative drug-dispensing contact lens delivers glaucoma medication continuously for a month

2013-12-09
Innovative drug-dispensing contact lens delivers glaucoma medication continuously for a month Biomaterials features findings of Mass. Eye and Ear, Harvard Medical School study BOSTON (Dec. 9, 2013) – For nearly half a century, contact lenses have ...

LAST 30 PRESS RELEASES:

Dementia takes 3.5 years to diagnose after symptoms begin

Robotic space rovers keep getting stuck. UW engineers have figured out why

New research shows how immigration status can become a death sentence during public health crisis

University of Toronto Engineering researchers develop safer alternative non-stick coating

Good vibrations: Scientists use imaging technology to visualize heat

More ecological diversity means better nutritional resources in Fiji’s agroforests

New global study shows freshwater is disappearing at alarming rates

Scientists create an artificial cell capable of navigating its environment using chemistry alone

A little salt is good for battery health

Deep-sea fish confirmed as a significant source of ocean carbonate

How to keep kids with eating disorders home after hospital stay? Therapy

Sex differences affect efficacy of opioid overdose treatment

Aligning AI with Human Values and Well-Being

Engineering the next generation of experimental physics

The scuba diving industry is funding marine ecosystem conservation and employing locals

BATMAN brings TCR therapy out of the shadows

Surrogates more likely to be diagnosed with mental illness, study finds

Columbia Engineering researchers turn dairy byproduct into tissue repair gel

Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024

Potential trade-offs of proposed cuts to the NIH

New research simulates cancer cell behavior

COVID, over 2.5 million deaths prevented worldwide thanks to vaccines. One life saved for every 5,400 doses administered

Scuba diving generates up to $20 billion annually

Scientists advance efforts to create ‘virtual cell lab’ as testing ground for future research with live cells

How DNA packaging controls the “genome’s guardian”

Simplified models, deeper insights: Coarse-grained models unlock new potential for ionic liquid simulations

Gorillas’ personal circumstances shape their aggression towards groupmates

Which signalling pathways in the cell lead to possible therapies for Parkinson's disease

Identifying landslide threats using hydrological predictors

First graders who use more educational media spend more time reading

[Press-News.org] Boosting the immune system to treat brain cancer
Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth